AutoXpress® System (AXP®)
- Produced by U.S. Cesca Therapeutics (Netcord official partner), FDA cleared and highly compatible with BioArchive®
- The only automated processing system specially designed for stem cells harvesting
- Automated closed system, individual sterile processing to avoid sample mix-up
- Most used automated cord blood processing system in both Asia and U.S. regions. Among all automated system processing cord blood samples, over 75% samples are processed by AXP®31
- The highest Mononuclear cell (MNC) - 98.7% and Total nucleated cell (TNC) - 96.2% recoveries in the industry, 18% higher than other systems (Sepax®)16
- MNC content will be used instead of TNC:
- As an indicator of cord blood unit quality
- Criteria of selecting sample for transplant27
- XpressTRAK™ software compatible with international ISBT barcode for global information tracking
Maximizing the Stem Cells Extraction
AutoXpress® (AXP®) Platform is the mostly adopted cord blood processing system (including New York Blood Centre and the largest Cord Blood Registry of U.S.). The system can collect 98.7 stem cells per 100 stem cells. Since the success of transplantation is determined by the quantity and viability of stem cells, HealthBaby therefore adopts the AXP® to maximize the extract of stem cells.
The claim of Sepax® ability to extract 99.46% TNC lacks of objectivity since the data is only from the cord blood bank's own experiment but not an objective third party. But according to the third parties, The American Congress of Obstetricians and Gynecologists and the largest Cord Blood Registry of U.S., Sepax® can only extract 80.3% of TNC but not 99.46%. Beware and do not be misled. In addition, only MNC but not TNC should be the criteria of transplant sample standard27.
HealthBaby Consultant
AutoXpress® - Maximizing the Stem Cells Extraction
AXP® System |
Other System | ||
|---|---|---|---|
| Specificity |
|
|
|
| Stem Cells Retrieval Rate |
|
|
|
| Operation |
|
|
|
| Global Usage |
|
|
|
| Recall Problem |
|
||
